Skip to main content
Clinical Trials/NCT02349880
NCT02349880
Completed
Not Applicable

A Shared Decision-making Training for Inpatients With Schizophrenia

Technical University of Munich0 sites264 target enrollmentOctober 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
Technical University of Munich
Enrollment
264
Primary Endpoint
adherence to antipsychotic medication
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

"Shared decision-making" is being promoted as a promising approach for engaging patients with schizophrenia in medical decisions and improving satisfaction and adherence.

To implement shared decision-making, both physicians and patients should commit to it and engage in a mutual decision process. Most research, however, has addressed interventions that either focus on the doctors' side (e.g. "communication skills") or on informing patients about treatment options (e.g. "decision aids"). These approaches have been shown to be feasible in clinical practice but had no strong effects on treatment patterns or adherence, possibly because they were insufficient to motivate and enable patients to engage actively in decision-making. Moreover, these interventions still rely on the doctor's willingness to share decisions, which has been shown to vary considerably.

To overcome these limitations and since many patients do not feel competent to participate in decision-making we developed an intervention that focuses on patients' communicative competencies. this intervention, a five session group-training, will be implemented for inpatients suffering from schizophrenia.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
March 2015
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Technical University of Munich
Responsible Party
Principal Investigator
Principal Investigator

Johannes Hamann

PI

Technical University of Munich

Eligibility Criteria

Inclusion Criteria

  • age 18-65
  • icd diagnosis F2
  • sufficient German language skills

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

adherence to antipsychotic medication

Time Frame: 12 months

Similar Trials